Johnson and Johnson has delayed the roll-out of its COVID-19 vaccine in Europe as reports of rare blood clots in the US are investigated.
American authorities have put a pause on the vaccine as they examine 6 reported cases among the 6.8 million doses given.
The first doses of the single-shot Johnson and Johnson vaccine had been due to arrive in Ireland this week.
